Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Pivotal (phase 3) studies for new drugs approved by the Food and Drug Administration (FDA) of the United States cost a median of $41,117 per patient.

https://www.sofpromed.com/how-much-does-a-clinical-trial-cost/

A study published by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, gave an estimated cost of $2.6 billion. That study broke down the number to include approximate average out-of-pocket costs of $1.4 billion and time costs of $1.2 billion.

https://www.biospace.com/article/median-cost-of-bringing-a-new-drug-to-market-985-million/

RAM, IF YOU WANT OFF-PANDEMIC TRIAL PRICES, WHY NOT WAIT UNTIL THE PANDEMIC IS OVER??? RAM, DO INVESTORS A FAVOR, CALL NEURO RX AND TELL THEM THE $4 M CHECK IS IN THE MAIL!!!